Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression
, , , , , , , , und | 13. Apr. 2022
Über diesen Artikel
Online veröffentlicht: 13. Apr. 2022
Seitenbereich: 427 - 436
Akzeptiert: 19. Jan. 2022
DOI: https://doi.org/10.2478/acph-2022-0029
Schlüsselwörter
© 2022 Jiamin Du et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Jiamin Du
Zhejiang Province Key Laboratory of Anticancer Drug Research,
College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Meijia Qian
Zhejiang Province Key Laboratory of Anticancer Drug Research,
College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Tao Yuan
Zhejiang Province Key Laboratory of Anticancer Drug Research,
College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Bo Zhang
Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province,
Affiliated Hangzhou First People’s Hospital, Zhejiang University School of MedicineHangzhou, China
Xueqin Chen
Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province,
Affiliated Hangzhou First People´s Hospital, Zhejiang University School of MedicineHangzhou, China
Ning An
Department of Pharmacy,
Ningbo Medical Center Lihuili Hospital
Ningbo, China
Qiaojun He
Zhejiang Province Key Laboratory of Anticancer Drug Research,
College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Bo Yang
Zhejiang Province Key Laboratory of Anticancer Drug Research,
College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Song Ye
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery,
The Second Affiliated Hospital, School of Medicine Zhejiang UniversityHangzhou, China
Hong Zhu
Zhejiang Province Key Laboratory of Anticancer Drug Research,
College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province,
Affiliated Hangzhou First People’s Hospital, Zhejiang University School of MedicineHangzhou, China
The Westlake Laboratory of Life Sciences and Biomedicine,
Hangzhou, China